October 29, 2020 | Portfolio News

Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

39

Level I Clinical Trials

31

Strategic Financings

31

Exits by IPO or M&A